61. Cholera - Status of Oral, Live Vaccines
Session: Symposium: Vaccines for a Global Community: Meningococcus A and B, Cholera, and Malaria
Thursday, October 20, 2011: 1:30 PM
Room: 205ABC

Myron Levine, MD, FIDSA, University of Maryland, Baltimore, MD

MYRON M. LEVINE, M.D., D.T.P.H., is Director of the Center for Vaccine Development, Head - Division of Geographic Medicine, Professor of Medicine, Pediatrics, Microbiology and Immunology, and Epidemiology and Preventive Medicine at the University of Maryland School of Medicine, Baltimore. He received the M.D. degree (1967) from the Medical College of Virginia, Richmond, and the D.T.P.H. diploma (1974) from the London School of Hygiene and Tropical Medicine, England. He has extensive experience in design and evaluation of vaccines to prevent bacterial enteric infections, particularly Salmonella. Dr. Levine is one of the most vocal advocates of mucosal immunization, i.e., the administration of vaccines by oral and intranasal routes to avoid the unpleasantness and occasional dangers of parenteral injections. He has made substantial contributions in basic vaccinology, bacterial pathogenesis, clinical research, field epidemiology and public health. In recent years, his basic laboratory research has focused on the use of attenuated Salmonella Typhi as live oral typhoid vaccines and as live vector vaccines that express the protective antigens of unrelated pathogens and deliver them to the human immune system. His clinical research has involved studies of pathogenesis and the assessment of a variety of vaccines in adults and children in Baltimore, as well as in many developing countries. Dr. Levine has been a pioneer in carrying out clinical trials in developing countries, including studies of vaccines developed at the CVD. Dr. Levine currently sits on the editorial boards of several major research journals, is a consultant to many organizations including the World Health Organization, NIH, the Vaccine Research Center, Institute of Medicine and the U.S. Department of Defense. Dr. Levine has authored/co-authored 504 scientific articles, 114 chapters and is Senior Editor of New Generation Vaccines, 4th ed. published in 2010.

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.